LE HR (Letrozole 2.5 mg)
Pill with imprint LE HR is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by Jiangsu Hengrui Pharmaceutical Co., Ltd.
Letrozole is used in the treatment of breast cancer, metastatic; breast cancer; breast cancer, adjuvant and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for LE HR
Letrozole
- Imprint
- LE HR
- Strength
- 2.5 mg
- Color
- Yellow
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Aromatase inhibitors, Hormones/antineoplastics
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Jiangsu Hengrui Pharmaceutical Co., Ltd.
- National Drug Code (NDC)
- 57884-2021
- Inactive Ingredients
-
lactose monohydrate,
microcrystalline cellulose,
sodium starch glycolate type A potato,
corn starch,
silicon dioxide,
magnesium stearate,
water,
hypromellose 2910 (6 mPa.s),
titanium dioxide,
polyethylene glycol 400,
ferric oxide red,
ferrosoferric oxide
Note: Inactive ingredients may vary.
Related images for "LE HR"
More about letrozole
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (324)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: aromatase inhibitors
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.